AMD vs. LLY: Advanced Micro Devices vs. Eli Lilly Stock Comparison
How do Advanced Micro Devices (AMD) and Eli Lilly (LLY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Advanced Micro Devices (AMD) is classified in the Information Technology sector (Semiconductors & Semiconductor Equipment), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AMD | LLY |
|---|---|---|
| Name | Advanced Micro Devices Inc. | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Semiconductors & Semiconductor Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Semiconductors & Semiconductor Equipment | Pharmaceuticals |
| GICS Sub-Industry | Semiconductors | Pharmaceuticals |
| Market Capitalization | 736.46 billion USD | 1,206.07 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | March 17, 1980 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | AMD | LLY |
|---|---|---|
| Total Return (1Y) | 114.18% | 52.36% |
| Total Return (3Y, Annualized) | 63.95% | 34.18% |
| Total Return (5Y, Annualized) | 27.42% | 41.08% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
Advanced Micro Devices (AMD) has a highly aggressive beta of 2.53, indicating much higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.40 and tends to be less market-sensitive — a wide gap in beta profiles.
| Metric | AMD | LLY |
|---|---|---|
| Volatility (1Y, Annualized) | 72.86% | 35.34% |
| Beta (5Y) | 2.53 | 0.40 |
| Max Drawdown (5Y) | -65.45% | -34.48% |
| Avg. Volume (3M) | 22.40M | 2.52M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | AMD | LLY |
|---|---|---|
| Sharpe Ratio (1Y) | 1.51 | 1.36 |
| Sortino Ratio (1Y) | 2.32 | 2.29 |
Profitability
ROE (TTM)
Eli Lilly (LLY) at 86.02% sits in the top ROE quartile, while Advanced Micro Devices (AMD) at 11.96% is closer to the peer norm — stronger capital efficiency for LLY.
AMD
Semiconductors & Semiconductor Equipment industry group
11.96%
- Max
- 52.82%
- Q3
- 22.26%
- AMD
- 11.96%
- Median
- 10.58%
- Q1
- 1.29%
- Min
- -16.89%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
86.02%
- Max
- 109.18%
- LLY
- 86.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
Net Margin (TTM)
Eli Lilly (LLY) at 31.90% converts revenue to bottom-line profit above its industry’s benchmark range, while Advanced Micro Devices (AMD) at 16.77% keeps roughly the typical share for its industry.
AMD
Semiconductors & Semiconductor Equipment industry group
16.77%
- Max
- 63.80%
- Q3
- 28.36%
- AMD
- 16.77%
- Median
- 11.44%
- Q1
- 0.90%
- Min
- -37.77%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
31.90%
- LLY
- 31.90%
- Max
- 18.05%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
Operating Margin (TTM)
Eli Lilly (LLY) at 53.66% operates in the top operating margin quartile, ahead of Advanced Micro Devices (AMD) at 21.17%, which runs around its industry’s norm.
AMD
Semiconductors & Semiconductor Equipment industry group
21.17%
- Max
- 58.66%
- Q3
- 30.23%
- AMD
- 21.17%
- Median
- 15.91%
- Q1
- 7.54%
- Min
- -25.74%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
53.66%
- Max
- 83.12%
- LLY
- 53.66%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
Profitability Metrics
| Metric | AMD | LLY |
|---|---|---|
| ROE (TTM) | 11.96% | 86.02% |
| ROA (TTM) | 5.90% | 21.06% |
| Net Margin (TTM) | 16.77% | 31.90% |
| Operating Margin (TTM) | 21.17% | 53.66% |
| Gross Margin (TTM) | 56.00% | 83.63% |
Growth
Revenue Growth
Advanced Micro Devices (AMD) at 34.34% sits in the top revenue growth quartile, while Eli Lilly (LLY) at 44.70% is closer to the peer norm — faster top-line expansion for AMD.
EPS Growth
Both companies show strong earnings momentum, but Advanced Micro Devices (AMD) at 165.00% is the standout with EPS growth above its industry range; Eli Lilly (LLY) at 95.99% also sits in the top quartile.
Growth Metrics
| Metric | AMD | LLY |
|---|---|---|
| Revenue Growth (YoY) | 34.34% | 44.70% |
| Revenue Growth (3Y CAGR) | 13.64% | 31.69% |
| EPS Growth (YoY) | 165.00% | 95.99% |
| EPS Growth (3Y CAGR) | 46.66% | 51.71% |
Financial Strength
Current Ratio (MRQ)
Advanced Micro Devices (AMD) at 2.73 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.39 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
AMD
Semiconductors & Semiconductor Equipment industry group
2.73
- Max
- 10.33
- Q3
- 5.62
- Median
- 3.33
- AMD
- 2.73
- Q1
- 2.35
- Min
- 1.03
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- LLY
- 1.39
- Min
- 0.10
Debt / Equity (MRQ)
Advanced Micro Devices (AMD) at 0.13 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.23 uses more debt funding than most peers.
AMD
Semiconductors & Semiconductor Equipment industry group
0.13
- Max
- 1.46
- Q3
- 0.65
- Median
- 0.27
- AMD
- 0.13
- Q1
- 0.04
- Min
- 0.00
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.23
- Max
- 1.42
- LLY
- 1.23
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | AMD | LLY |
|---|---|---|
| Current Ratio (MRQ) | 2.73 | 1.39 |
| Debt / Equity (MRQ) | 0.13 | 1.23 |
| Net Debt / EBITDA | -0.59 | 0.96 |
Dividends
Dividend Yield (TTM)
Advanced Micro Devices (AMD) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a yield of 0.49%, ranking against industry peers normally.
AMD
Semiconductors & Semiconductor Equipment industry group
0.00%
- Max
- 1.37%
- Q3
- 0.65%
- AMD
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.49%
- LLY
- 0.49%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Advanced Micro Devices (AMD) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a payout of 21.71%, ranking against industry peers normally.
AMD
Semiconductors & Semiconductor Equipment industry group
0.00%
- Max
- 49.64%
- Q3
- 21.71%
- AMD
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.71%
- LLY
- 21.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | AMD | LLY |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.49% |
| Dividend Payout Ratio (TTM) | 0.00% | 21.71% |
Valuation
P/E Ratio (TTM)
Both Advanced Micro Devices (AMD) at 95.95 and Eli Lilly (LLY) at 43.95 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.
AMD
Semiconductors & Semiconductor Equipment industry group
95.95
- Max
- 110.34
- AMD
- 95.95
- Q3
- 66.81
- Median
- 37.02
- Q1
- 23.96
- Min
- 8.12
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
43.95
- Max
- 85.34
- LLY
- 43.95
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
P/S Ratio (TTM)
Eli Lilly (LLY) at 13.95 is priced about in line with its industry on P/S ratio, while Advanced Micro Devices (AMD) at 16.21 sits in the pricier quartile — AMD costs more per dollar of sales.
AMD
Semiconductors & Semiconductor Equipment industry group
16.21
- Max
- 21.42
- AMD
- 16.21
- Q3
- 12.27
- Median
- 5.76
- Q1
- 2.73
- Min
- 0.00
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.95
- Max
- 58.18
- Q3
- 25.77
- LLY
- 13.95
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
P/B Ratio (MRQ)
Both look rich against book: Advanced Micro Devices (AMD) at 10.77 sits in the upper P/B ratio quartile, and Eli Lilly (LLY) at 29.96 prices even higher, above its industry range.
AMD
Semiconductors & Semiconductor Equipment industry group
10.77
- Max
- 14.06
- AMD
- 10.77
- Q3
- 7.44
- Median
- 4.29
- Q1
- 2.30
- Min
- 0.20
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.96
- LLY
- 29.96
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
Valuation Metrics
| Metric | AMD | LLY |
|---|---|---|
| P/E Ratio (TTM) | 95.95 | 43.95 |
| P/S Ratio (TTM) | 16.21 | 13.95 |
| P/B Ratio (MRQ) | 10.77 | 29.96 |
| Free Cash Flow Yield (TTM) | 1.00% | 0.77% |